What is Simcere Pharmaceutical Group Inventory-to-Revenue?
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Simcere Pharmaceutical Group's Average Total Inventories for the quarter that ended in Dec. 2023 was HK$704 Mil. Simcere Pharmaceutical Group's Revenue for the
six
months ended in Dec. 2023 was HK$3,531 Mil.
Simcere Pharmaceutical Group's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.20.
Simcere Pharmaceutical Group's Inventory-to-Revenue for the quarter that ended in Dec. 2023
increased
from Jun. 2023 (0.15) to Jun. 2023 (0.20)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Simcere Pharmaceutical Group's Days Inventory for the
six
months ended in Dec. 2023 was 145.89.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Simcere Pharmaceutical Group's Inventory Turnover for the quarter that ended in Dec. 2023 was 1.25.
Simcere Pharmaceutical Group Inventory-to-Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Simcere Pharmaceutical Group Inventory-to-Revenue Chart
Competitive Comparison of Simcere Pharmaceutical Group's Inventory-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Simcere Pharmaceutical Group's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Simcere Pharmaceutical Group's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Simcere Pharmaceutical Group's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where Simcere Pharmaceutical Group's Inventory-to-Revenue falls into.
Simcere Pharmaceutical Group Inventory-to-Revenue Calculation
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Simcere Pharmaceutical Group's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Simcere Pharmaceutical Group (HKSE:02096) Inventory-to-Revenue Explanation
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Simcere Pharmaceutical Group's Days Inventory for the
six
months ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Simcere Pharmaceutical Group Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of Simcere Pharmaceutical Group's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Simcere Pharmaceutical Group (HKSE:02096) Business Description
Simcere Pharmaceutical Group Ltd is engaged in the R&D, production and commercialization of pharmaceuticals focused on generic pharmaceuticals. It has a diversified product portfolio focused on therapeutic areas, including, oncology (including cell therapy), nervous system diseases, autoimmune diseases and antiinfection. The company's products include Endostar, Enweida, Iremod, Sanbexin and Others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02096 has been successfully added to your 